{'fraction_non_alphanumeric': 0.018209408194233688, 'fraction_numerical': 0.0, 'mean_word_length': 6.173913043478261, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Management of dyspnea in advanced lung cancer: recent data and emerging concepts

Purpose of reviewOne of the most common symptoms for lung cancer patients, dyspnea, can seriously impact patients' quality of life. Recent findingsAlongside conventional disease-focused approaches in lung cancer treatment, notably surgery, chemotherapy, and radiation therapy, physicians and researchers alike are increasingly attending to symptom control and seeking to evaluate the effectiveness of available interventions in mitigating symptoms. SummaryThis study reviews several interesting advances in the area of dyspnea with respect to symptom assessment and management.